World Anti-Doping Agency (WADA) on 6 July 2015 released new Guidelines with recommended practices for several aspects of anti-doping programming.
These model guidelines are not mandatory, but offer technical guidance to ADOs in the implementation of programs.
WADA Guidelines includes
• Reporting & Management of Urinary Human Chorionic Gonadotrophin (hCG) and Luteinizing Hormone (LH) Findings in Male Athletes, v2.0. These Guidelines replace the current hCG Guidelines, v1.0 September 2011, and incorporate important changes in the testing methods for hCG and the reporting and management of hCG findings. This modified version of the hCG Guidelines also provides instructions and recommendations on the testing and reporting of LH findings.
• Human Growth Hormone (hGH) Biomarkers Test for Doping Control Analyses, v1.0. These new Guidelines have been developed to ensure a harmonized approach in the application of the GH-2000 Biomarkers Test for the detection of doping with human Growth Hormone (hGH) in sport. This version provides direction on the sample pre-analytical preparation procedure, the performance of the test and the interpretation of the test results.
Now get latest Current Affairs on mobile, Download # 1 Current Affairs App
When: 6 July 2015
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.